Previous Close | 2.7800 |
Open | 2.7800 |
Bid | 2.8300 x 100 |
Ask | 2.8600 x 200 |
Day's Range | 2.7000 - 2.8650 |
52 Week Range | 1.4500 - 4.9100 |
Volume | |
Avg. Volume | 380,493 |
Market Cap | 202.143M |
Beta (5Y Monthly) | 2.08 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.1300 |
Earnings Date | Oct 31, 2024 - Nov 04, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 6.86 |
When a single insider purchases stock, it is typically not a major deal. However, when multiple insiders purchase...
REDWOOD CITY, Calif., Sept. 06, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the approval of equity grants to three new employees as approved by the Compensation Committee of Codexis’ Board of Directors. The newly hired employees received equity awards consisting of an aggregate of (i) options to purchase 4,950 shares of Codexis common stock and (ii) 8,125 restricted stock units (RSUs) as inducement awards under the company’s 2024 I
REDWOOD CITY, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced that management will participate in two upcoming investor conferences. The Cantor Global Healthcare Conference (New York, NY) Tuesday, September 17, 2024, at 11:30 am ET, management will participate in a fireside chat The Craig-Hallum Bioprocessing Conference (Virtual) Thursday, September 19, 2024, at 2:00 pm ET, management will participate in a fireside ch